Rasagiline 0.5 mg Tablet (Rasagiline Mesylate)

Adult dose

This medicine is administered orally once daily to adults as monotherapy or adjunctive therapy. 1) Monotherapy or adjunctive therapy to a dopamine agonist: Administer 1mg orally once daily. 2) Adjunctive therapy to levodopa: The recommended initial dose for patients taking levodopa is 0.5mg once daily. If it is well tolerated and an adequate clinical response is not achieved, the dose may be increased to 1mg once daily. This medicine may be taken with or without food.

This medication should not be used by individuals who are allergic to the active ingredient or other components. It should also not be used by those currently taking or who have recently stopped taking other MAO inhibitors, certain painkillers, or cough medications. Patients with moderate to severe liver dysfunction should not take this medication. Caution is advised as various side effects including cold, headache, dizziness, depression, hallucinations, dermatitis, myalgia, etc., can occur. Particularly, when used with dopamine-related medications, symptoms such as drowsiness, hypotension, and impulse control disorders may arise, so doctor's guidance is necessary. This medication may affect the ability to drive or operate machinery; thus, activities that could be dangerous should be avoided if drowsiness or sleep attacks occur. Furthermore, interactions with certain foods or other medications can lead to serious side effects such as hypertensive crises or serotonin syndrome, thus caution should be exercised. Pregnant or breastfeeding women should be cautious while taking this medication, and safety in individuals under 18 years has not been established. In case of overdose, severe side effects may occur, requiring immediate visit to a medical facility; this medication should be kept out of reach of children.

Influenza

This medication should be stored in a tightly sealed container to protect it from air and moisture. Additionally, it should be kept in a cool place, at a temperature ranging from 1 to 25 degrees Celsius, to maintain its efficacy.

Appearance

Flat, round tablets with corners, white or almost white

Package unit

30 tablets/bottle